40 research outputs found
Diabetes Mellitus in cats : practical advice to veterinary medical staff
Diabetes mellitus är en av kattens vanligaste endokrina sjukdomar. Diabetes mellitus ger ett tillstånd där blodglukoskoncentrationen är förhöjd vilket resulterar i hyperglykemi. Diabetes är en speciell sjukdom då djurägaren har en viktig roll i behandlingen och skötseln av den diabetessjuka katten. Det är djursjukskötaren som till största delen står för den praktiska träningen och rådgivningen kring provtagningstekniker och insulinbehandling och det krävs då att man som djursjuksötare har vetskap och kunskap om sjukdomen diabetes mellitus samt vad sjukdomen innebär för djurägaren.
Insulin är det fösta som sätts in som behandling vid konstaterad diabetes.
Litteraturstudier har gjorts i vetenskapliga artiklar och böcker, djurägare till diabeteskatter har intervjuats och en djursjukskötare har intervjuats.
Resultatet från intervjuerna med djurägarna visar att det blir en helt ny omställning i livet att leva med en diabeteskatt både för katten och också för djurägaren. Många djurägare blir oroliga och fundersamma till en början och känner sig osäkra inför den behandling och skötsel som väntar. Trots detta är de flesta villiga att lära sig och positivt inställda och även nöjda med den träning och det bemötande de får på djursjukhuset. Genom att ge fler träningstillfällen samt utforma informationsbroschyrer eller demonstrationsfilmer som endast berör katt anser både djurägare och personal att utbildningen skulle kunna bli ännu bättre så att missförstånd och felbehandlingar kan undvikas
Lowered expression of tumor suppressor candidate MYO1C stimulates cell proliferation, suppresses cell adhesion and activates AKT
Myosin-1C (MYO1C) is a tumor suppressor candidate located in a region of recurrent
losses distal to TP53. Myo1c can tightly and specifically bind to PIP2, the substrate of Phosphoinositide
3-kinase (PI3K), and to Rictor, suggesting a role for MYO1C in the PI3K pathway.
This study was designed to examine MYO1C expression status in a panel of wellstratified
endometrial carcinomas as well as to assess the biological significance of
MYO1C as a tumor suppressor in vitro. We found a significant correlation between the
tumor stage and lowered expression of MYO1C in endometrial carcinoma samples. In cell
transfection experiments, we found a negative correlation between MYO1C expression
and cell proliferation, and MYO1C silencing resulted in diminished cell migration and adhesion.
Cells expressing excess of MYO1C had low basal level of phosphorylated protein
kinase B (PKB, a.k.a. AKT) and cells with knocked down MYO1C expression showed a
quicker phosphorylated AKT (pAKT) response in reaction to serum stimulation. Taken
together the present study gives further evidence for tumor suppressor activity of MYO1C
and suggests MYO1C mediates its tumor suppressor function through inhibition of PI3K
pathway and its involvement in loss of contact inhibition.Royal Physiographic Society in Lund
(Nilsson-Ehle Foundation) with grant numbers
30928, 32705 and 36388: KV. Wilhelm and Martina
Lundgren Foundation: KV, AB. Assar Gabrielsson
Research Foundation for Clinical Cancer Research
with grant numbers FB11-15, FB12-26, FB13-05,
FB14-46 and FB15-45: KV. Sahlgrenska University
Hospital Foundation with grant number 8181: KV. The Knowledge Foundation with grant number
HOÈ G12, 20120311: AB.http://www.plosone.orgam2016Physiolog
Genetic characterization of large parathyroid adenomas
In this study, we genetically characterized parathyroid adenomas with large glandular weights, for which independent observations suggest pronounced clinical manifestations. Large parathyroid adenomas (LPTAs) were defined as the 5% largest sporadic parathyroid adenomas identified among the 590 cases operated in our institution during 2005–2009. The LPTA group showed a higher relative number of male cases and significantly higher levels of total plasma and ionized serum calcium (P<0.001). Further analysis of 21 LPTAs revealed low MIB1 proliferation index (0.1–1.5%), MEN1 mutations in five cases, and one HRPT2 (CDC73) mutation. Total or partial loss of parafibromin expression was observed in ten tumors, two of which also showed loss of APC expression. Using array CGH, we demonstrated recurrent copy number alterations most frequently involving loss in 1p (29%), gain in 5 (38%), and loss in 11q (33%). Totally, 21 minimal overlapping regions were defined for losses in 1p, 7q, 9p, 11, and 15q and gains in 3q, 5, 7p, 8p, 16q, 17p, and 19q. In addition, 12 tumors showed gross alterations of entire or almost entire chromosomes most frequently gain of 5 and loss of chromosome 11. While gain of 5 was the most frequent alteration observed in LPTAs, it was only detected in a small proportion (4/58 cases, 7%) of parathyroid adenomas. A significant positive correlation was observed between parathyroid hormone level and total copy number gain (r=0.48, P=0.031). These results support that LPTAs represent a group of patients with pronounced parathyroid hyperfunction and associated with specific genomic features
Running GAGs: myxoid matrix in tumor pathology revisited: What’s in it for the pathologist?
Ever since Virchow introduced the entity myxoma, abundant myxoid extracellular matrix (ECM) has been recognized in various reactive and neoplastic lesions. Nowadays, the term “myxoid” is commonly used in daily pathological practice. But what do today’s pathologists mean by it, and what does the myxoid ECM tell the pathologist? What is known about the exact composition and function of the myxoid ECM 150 years after Virchow? Here, we give an overview of the composition and constituents of the myxoid ECM as known so far and demonstrate the heterogeneity of the myxoid ECM among different tumors. We discuss the possible role of the predominant constituents of the myxoid ECM and attempt to relate them to differences in clinical behavior. Finally, we will speculate on the potential relevance of this knowledge in daily pathological practice
Novel Clonal t(2;4) (q23;p14) Secondary Cytogenetic Abnormality in a Primary Myxoid Liposarcoma
No difference between smoking lung cancer patients and smoking controls in the frequency of spontaneous and mitomycin C induced chromosome aberrations in lymphocytes
Cytogenetic findings in 33 osteosarcomas
Thirty-three osteosarcomas (OS) were analyzed cytogenetically. Clonal chromosome changes were detected in 17 cases. Six tumors had chromosome numbers in the diploid range, 6 in the triploid range, 1 in the tetraploid range and 1 in the pentaploid range, while 3 tumors had multiple clones with different ploidy levels. Including the present 17 tumors, a total of 27 OS with clonal aberrations have been reported. The recognizable structural rearrangements in these 27 tumors clustered to chromosome arms 1p, 1q, 3p, 3q, 7q, 11p, 17p and 22q. Chromosome bands 1q11, 1q21, 1q42 and 7q11 were the most frequently rearranged, and the most common numerical rearrangements were -3, -10, -13 and -15. Supernumerary ring chromosomes, in 2 tumors as the sole change, were found in all 3 parosteal OS, which is in agreement with the findings in 1 previously reported parosteal OS. The association between ring formation and parosteal morphology represents the first cytogenetic-morphologic entity among OS